Work

Optimal infection prophylaxis strategy for relapsed/refractory multiple myeloma patients undergoing elranatamab therapy (OPTIMUS-EL)

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-8237

Authors: Ja Min Byun, Dong Hyun Kim, Youngil Koh, Chang-Ki Min, Kihyun Kim, Hee Jeong Cho, Ji Yun Lee

Institutions: Seoul National University Hospital, Catholic University of Korea, Samsung Medical Center, Sungkyunkwan University, Kyungpook National University Hospital, Seoul National University Bundang Hospital

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417015351

Cites:

Cited by:

Related to: